1938 297 water soluble
Cephalothin 1978 305 water soluble
Cisplatin 2319 361 water soluble
Colistin 2475 387 suspension
+ surfac-
tant
Cytarabine 2790 437 water soluble
Dactinomycin 2804 441 water
1938 297 water soluble
Cephalothin 1978 305 water soluble
Cisplatin 2319 361 water soluble
Colistin 2475 387 suspension
+ surfac-
tant
Cytarabine 2790 437 water soluble
Dactinomycin 2804 441 water
1938 297 water soluble
Cephalothin 1978 305 water soluble
Cisplatin 2319 361 water soluble
Colistin 2475 387 suspension
+ surfac-
tant
Cytarabine 2790 437 water soluble
Dactinomycin 2804 441 water
1938 297 water soluble
Cephalothin 1978 305 water soluble
Cisplatin 2319 361 water soluble
Colistin 2475 387 suspension
+ surfac-
tant
Cytarabine 2790 437 water soluble
Dactinomycin 2804 441 water
6, 1389; Van Den Brule,
F. A., et al. 2000. Int. J. Cancer 89, 361; Inohara, H. 1999. Cancer 85, 2475; Ochieng,
J., et al. 1998. Biochim. Biophys. Acta. 1379 97; Castronovo, V., et al. 1996. J. Pathol
366 R4653 3181 HNRNPA2B1 M NP 002128 y y y
431 MAP2 (2a+2b) 4133 MAP2 M
471 mTOR T2949 2475 FRAP1 P NP_004949.1 y y y
401 Ku Antigen K2882 2547 XRCC6 M NP_001460.1 y n/d n/d
290 Glutamic Acid
366 R4653 3181 HNRNPA2B1 M NP 002128 y y y
431 MAP2 (2a+2b) 4133 MAP2 M
471 mTOR T2949 2475 FRAP1 P NP_004949.1 y y y
401 Ku Antigen K2882 2547 XRCC6 M NP_001460.1 y n/d n/d
290 Glutamic Acid
366 R4653 3181 HNRNPA2B1 M NP 002128 y y y
431 MAP2 (2a+2b) 4133 MAP2 M
471 mTOR T2949 2475 FRAP1 P NP_004949.1 y y y
401 Ku Antigen K2882 2547 XRCC6 M NP_001460.1 y n/d n/d
290 Glutamic Acid
MTA3 NP_065795.1 P y n/d n/d
470 MTBP M3566 27085 MTBP NP_071328.2 P y n/d n/d
471 mTOR T2949 56718, 2475, 56717 Frap1,FRAP1 NP_063971.1,NP_004949.1,NP_064393.1 P y y y
472 Munc-18-1 M2694 20910, 6812, 25558
MTA3 NP_065795.1 P y n/d n/d
470 MTBP M3566 27085 MTBP NP_071328.2 P y n/d n/d
471 mTOR T2949 56718, 2475, 56717 Frap1,FRAP1 NP_063971.1,NP_004949.1,NP_064393.1 P y y y
472 Munc-18-1 M2694 20910, 6812, 25558